Table 1.
Clinical and pathological characterization of non-IBC versus IBC patients.
| Characteristic | Non-IBC (N = 39) | IBC(N = 27) | p value |
|---|---|---|---|
| Age | 0.08a | ||
| Range | 33–72 | 29–65 | |
| Mean | 52 ± 1.9 | 42 ± 1.8 | |
| NA | 2 | 0 | |
| Tumor size† | 0.05b | ||
| Mean ± SD | 4.2 ± 2.6 | 4.9 ± 3.6 | |
| <4 | 22(61%) | 7 (34%) | |
| >4 | 14 (39%) | 14(66%) | |
| NA | 3 | 1 | |
| Number of lymph nodes | 0.003*b | ||
| <4 | |||
| >4 | 20(54%) | 4 (16%) | |
| NA | 17(46%) | 21(84%) | |
| 2 | 2 | ||
| ER | 0.4b | ||
| Negative | 23 (59%) | 19(70%) | |
| Positive | 16 (51%) | 8 (30%) | |
| NA | 0 | 0 | |
| PR | 1.0b | ||
| Negative | 25(67%) | 17 (63%) | |
| Positive | 14(33%) | 10(37%) | |
| NA | 0 | 0 | |
| Her-2 | 0.7b | ||
| Negative | 32(79%) | 21(77%) | |
| Positive | 7(21%) | 6 (23%) | |
| NA | 0 | 0 | |
| Tumor grade | 0.4b | ||
| G1 | 2(6%) | 0(0%) | |
| G2 | 27(75%) | 21(77%) | |
| G3 | 7(19%) | 5(19%) | |
| G4 | 0(0%) | 1(4%) | |
| NA | 3 | 0 | |
| Tumor emboli | 0.0001*b | ||
| Negative | 35(89%) | 0(0%) | |
| Positive | 4(11%) | 27(100%) | |
| NA | 0 (0%) | 0(0%) |
Data are reported as mean ± SD.
NA: Data not available.
*
Significant p value calculated by
a
Student-t test or
b
Fisher’s exact test.
†
n = 22 (five IBC patients did not have a tumor mass).